Hallucinations during voriconazole therapy.
As part of a prospective natural history cohort study of voriconazole toxicity, we describe the characteristics of 12 of 72 voriconazole-treated patients who experienced hallucinations from March 2006 through November 2007. Hallucinations associated with voriconazole use are not uncommon. Doctors should be aware of this complication, and the recipients of the drug should be reassured that the hallucinations are an effect of the drug.
Zonios
Dimitrios I
DI
Laboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA.
Gea-Banacloche
Juan
J
Childs
Richard
R
Bennett
John E
JE
D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D006212:Hallucinations / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use; D014230:Triazoles / Q000009:adverse effects* / Q000627:therapeutic use; D065819:Voriconazole
D011743:Pyrimidines; D014230:Triazoles; D065819:Voriconazole